職位推薦
- 珍格醫(yī)療-臨床銷售 15001-20000
- 地奧制藥-醫(yī)藥代表 6001-8000
- 普利德醫(yī)療-醫(yī)療設(shè)備銷售經(jīng)理 面議
- 大唐-兼職招商經(jīng)理 面議
- 景德中藥-直營(yíng)經(jīng)理 6001-8000
- 安邦醫(yī)藥-省區(qū)招商經(jīng)理 8001-10000
- 恒瑞醫(yī)藥-醫(yī)藥信息溝通專員 6001-8000
- 黃河中藥-學(xué)術(shù)講師 8001-10000
發(fā)布日期:2017-05-12 瀏覽次數(shù):75
中山大學(xué)腫瘤防治中心2017年
博士后招聘啟事
中山大學(xué)腫瘤防治中心(中山大學(xué)附屬腫瘤醫(yī)院、中山大學(xué)腫瘤研究所)成立于1964年3月,是新中國(guó)成立最早的四所腫瘤醫(yī)院之一。中心是全國(guó)規(guī)模最大、學(xué)術(shù)力量最雄厚的集醫(yī)療、教學(xué)、科研、預(yù)防于一體的腫瘤學(xué)基地之一,學(xué)科地位、綜合實(shí)力居全國(guó)領(lǐng)先水平。
現(xiàn)實(shí)際開放病床數(shù)1489張,設(shè)有32個(gè)業(yè)務(wù)科室,8個(gè)職能處室,2個(gè)研究科室。2016年門診量達(dá)83萬余人次,出院人數(shù)近9.4萬余人次,醫(yī)療業(yè)務(wù)量居全國(guó)腫瘤專科醫(yī)院前列。醫(yī)療技術(shù)水平領(lǐng)先,擁有軟硬件條件亞洲一流的放射治療中心、開展多個(gè)專科手術(shù)機(jī)器人微創(chuàng)手術(shù)。
中心是國(guó)家重點(diǎn)學(xué)科(腫瘤學(xué))、國(guó)家重點(diǎn)實(shí)驗(yàn)室(華南腫瘤學(xué)國(guó)家重點(diǎn)實(shí)驗(yàn)室)。科技影響力穩(wěn)居“中國(guó)醫(yī)院科技影響力排行榜”(腫瘤學(xué))前兩位。共有75個(gè)項(xiàng)目獲得省部級(jí)以上科研成果獎(jiǎng)勵(lì),其中包括國(guó)家自然科學(xué)二等獎(jiǎng)1項(xiàng)、國(guó)家科技進(jìn)步二等獎(jiǎng)4項(xiàng)等。主辦英文學(xué)術(shù)期刊 Chinese Journal of Cancer,2014年被SCI收錄,2015年影響因子2.814,在國(guó)內(nèi)被收錄腫瘤學(xué)期刊中位列第一。
中心以優(yōu)秀的文化引才、聚才,凝聚高水平的醫(yī)教研隊(duì)伍,現(xiàn)有員工2645人。中心通過優(yōu)化管理體制,推進(jìn)軟硬件建設(shè),建成了就醫(yī)方便、流程合理、賓至如歸的花園式人文醫(yī)院;繼承“誠(chéng)實(shí)、友愛、敬業(yè)、創(chuàng)新”的文化因子,2016年榮獲中國(guó)醫(yī)療機(jī)構(gòu)最佳雇主排行榜冠軍。
中心擁有良好的科研平臺(tái)、完善的學(xué)科結(jié)構(gòu)和雄厚的經(jīng)費(fèi)支持,可為博士后提供優(yōu)厚的福利待遇和廣闊的發(fā)展空間。2017年面向海內(nèi)外招聘博士后研究人員79位,歡迎有志于腫瘤防治研究事業(yè)的優(yōu)秀博士畢業(yè)生加入!招聘事項(xiàng)如下:
一、招收條件:
1、取得博士學(xué)位,品學(xué)兼優(yōu),身心健康,具備較高的學(xué)術(shù)水平和較強(qiáng)的科研能力。
2、首次進(jìn)站人員年齡一般在35歲以下,博士畢業(yè)不超過兩年。企業(yè)、基地博士后、留學(xué)回國(guó)人員、外籍人員、擬進(jìn)二站人員、特別優(yōu)秀的人員年齡可放寬到40歲以下,無博士畢業(yè)與博士后進(jìn)站間隔年限限制。
3、科研博士后原則上不接受在職人員的申請(qǐng)。
4、在本校獲得博士學(xué)位的畢業(yè)生,不得申請(qǐng)進(jìn)入校內(nèi)相同一級(jí)學(xué)科的流動(dòng)站。
二、福利待遇:
1、年薪20-25萬元(稅前)
2、繳納五險(xiǎn)一金。
3、解決廣州市戶口。
4、在站期間業(yè)績(jī)優(yōu)秀,可申請(qǐng)本中心專職科研人員職位;在站期間發(fā)表IF 10以上論文,可根據(jù)崗位需要,申請(qǐng)調(diào)入。
三、出站要求:在站期間發(fā)表IF 3.0以上SCI論文1篇以上,獲得科研基金1項(xiàng)以上。
四、招聘人數(shù)及期限:77名,常年招聘,額滿為止。
五、招聘程序
1、申請(qǐng)者選擇合作導(dǎo)師,與導(dǎo)師溝通,確定合作意向。導(dǎo)師信息及專業(yè)要求見附件,也可在中山大學(xué)【博士后之家】或本中心官網(wǎng)【名醫(yī)名家】查閱。
2、投遞簡(jiǎn)歷。申請(qǐng)者可選擇以下三種方式投遞簡(jiǎn)歷:(1)將簡(jiǎn)歷發(fā)到合作導(dǎo)師郵箱;(2)將簡(jiǎn)歷上傳到在本中心誠(chéng)聘英才/博士后崗位;(3)將簡(jiǎn)歷發(fā)到由本中心人事處老師郵箱,由人事處老師推薦合作導(dǎo)師。
3、進(jìn)站面試。由本中心博士后管理小組專家對(duì)申請(qǐng)者進(jìn)行面試(國(guó)外申請(qǐng)者可進(jìn)行視頻面試)。申請(qǐng)者須做15-30分鐘學(xué)術(shù)報(bào)告,主要內(nèi)容包括申請(qǐng)者的基本情況,以往研究工作經(jīng)歷,今后的研究方向,以及與合作導(dǎo)師研究方向一致性等。
4、提交材料。申請(qǐng)者根據(jù)中山大學(xué)博士后之家/博士后進(jìn)站材料一覽表要求,進(jìn)入中國(guó)博士后網(wǎng)進(jìn)行網(wǎng)上申報(bào);準(zhǔn)備好相關(guān)材料,提交本中心人事處老師審核。
5、上報(bào)審批。由本中心人事處對(duì)應(yīng)聘者提交的材料進(jìn)行初審,通過初審的材料再提交中山大學(xué)博士后管理辦公室審核,最后報(bào)廣東省人事廳審批。此過程約需一個(gè)月左右。
六、聯(lián)系方式
聯(lián)系人:楊老師 文老師
聯(lián)系地址:廣州市越秀區(qū)東風(fēng)東路651號(hào) 中山大學(xué)腫瘤防治中心人事處
電話:020-87343130、87343129
QQ群(博雅齋):157357002
2017 SunYat-senUniversityCancerCenter
PostdoctoralPositions
Sun Yat-sen University Cancer Center (SYSUCC) was established in 1964 and is one of the four earliest tumor hospitals in China. SYSUCC is leading the way on a national frontier. It is the largest integrated cancer center in the whole of southern China for cancer care, education, research and prevention.
SYSUCC is a modern medical service provider equipped with 1489 ward beds, 32 clinical departments, 8 administrative offices and 2 research departments. In 2016, the center performed 830,000 out-patients consultations and 94,000 patients were hospitalized, providing the largest volume of cancer medical service in China. Equipped with state of the art medical technology, SYSUCC has a premier radiation therapy center and recently introduced the da Vinci robot for minimally invasive surgeries.
Sun Yat-sen University Cancer Center has been awarded many prestigious titles: the National Key Disciplines (Oncology), the State Key Laboratory (SKL) of Oncology in South China, etc. SYSUCC has always closely combined its clinical and research attributes, ranking top two in the Chinese Hospital of Scientific Impact Ranking.
Altogether,seventy-five projects have been awarded with scientific achievement awards of provincial level or above, including one project with the second prize of “National Natural Science Award”, four projects with the second prize of “National Science and Technology Progress Award”. SYSUCC houses the editorial office of the Chinese Journal of Cancer (CJC). In 2014, CJC became Science Citation Indexed (SCI), and its impact factor of 2015 reached 2.814, ranking first among the national journals of Oncology.
With over 2,500 staff members, Sun Yat-sen University Cancer Center has recruited a talented team for patient care, education and scientific research. Through infrastructure optimization, software and management system upgrades, SYSUCC has created an efficient working environment for its employees, as well as a patient-oriented atmosphere. In 2016, SYSUCC was ranked first in the Chinese Hospitals Best Employer Ranking.
With the establishment of high level research platforms, a mature discipline structure as well as strong funding support, SYSUCC is now offeringgenerous post-doctoral researcher benefits and promising career opportunities. In 2017, 79post-doctoral positions will be made availableat SYSUCC. Enthusiastic applicants with a recent PhDand related research background arestrongly encouraged to apply.Join us and investigate inthe fields of cancer treatment and prevention.
Eligibility Requirements:
1. Good general health, with a doctor’s degree, high academic achievements and strong research ability
2. For recent PhD graduates: you must be under the age of 35 and have completed your PhD degree within the last 2 years.
For Post-docs from industry, postdoctoral bases, abroad, foreign or outstanding applicants: must be under the age of 40.
3. To commit to a full-time employment position.
4. For SYSU PhD graduates only: you mustnot apply to the Postdoctoral Training Stationfor the same discipline.
Welfare and Benefits
1. Annual salary: 200,000 – 250,000 RMB (before tax)
2. Pay the basic social insurance and housing fund (for Chinese applicants)
3. Guangzhou hukou (for Chinese applicants)
4. Post-docs with excellent academic performance can apply for a researcher’s position in SYSUCC afterwards.
Requirement for Postdoctoral Training Completion
You must publish at least one SCI paper with an impact factor above 3.0and receive at least one research funding grant in order to gain the post-doc training certificate. Information and help about funding opportunities at that stage will be disclosed at a later date.
Total number of enrollment:77
Application procedure
1. Please communicate first with potential supervisors. Attached is the contact information and research specialty for each of the supervisors. You can also check SYSUCC official website or the following website: http://rsc.sysu.edu.cn/postdoctor/
2. Please submit your CV by: (1) sending it to your supervisor via email. (2) submit it online to our Chinese website(3)send it to our Human Resources Department, and we will then help to recommend you to suitable supervisors
3. Interview: experts from the Post-doc Administration Group are in charge of interviewing all applicants(international applicants can be interviewed via teleconferencing). A 15-30 minute academic presentation is required, including a general self-introduction, introduction of your former research experience as well as your future work plan.
4. Document submission: applicants should prepare all the materials as required (http://rsc.sysu.edu.cn/PostDoctor/Article/ShowArticle.asp?ArticleID=1088), and submit themto the following website: http://www.chinapostdoctor.org.cn/WebSite/program/Default.aspx Please prepare the related documents for review by our HR team.
5. Approval: After approval by our HR, documents will be submitted to the Office of Postdoctor Management at Sun Yat-sen University, and then to the Personnel Department of Guangdong Province for final approval. The whole procedure takes approximately 30 days.
Contact
Contact person: Mrs. Yang, Mrs. Wen
Address: Personnel Department, Sun Yat-sen University Cancer Center, No. 651 Dongfeng East Road, Yuexiu District, Guangzhou, China
Tel: 86 20 87343130, 86 20 87343129
Email: yangping@sysucc.org.cn
QQ: 157357002
附:招收信息
序號(hào) |
合作導(dǎo)師姓名Supervisor |
二級(jí)學(xué)科Second-level discipline |
研究方向Field of research |
招收人數(shù) | |||
中文 |
英文 |
中文 |
英文 |
中文 |
英文 | ||
1 |
夏小俊 |
Xiaojun Xia |
分子醫(yī)學(xué) |
Molecular Medicine |
天然免疫和腫瘤免疫治療 |
Innate immunity&Cancer immunotherapy |
2 |
2 |
劉學(xué)奎 |
XuekuiLiu |
頭頸腫瘤學(xué)/耳鼻喉科學(xué) |
Head and neck /oncologyotolaryngology |
喉癌的基礎(chǔ)和臨床研究 |
Basic and clinical research of laryngeal cancer |
1 |
3 |
曾益新 |
Yi-Xin Zeng |
腫瘤學(xué) |
Oncology |
惡性腫瘤的發(fā)病機(jī)理及腫瘤的生物治療 |
Mechanisms of cancer pathogenesis andbiotherapy |
2 |
4 |
黃必軍 |
Bi-Jun Huang |
腫瘤學(xué) |
oncology |
腫瘤干細(xì)胞 |
Cancer stem cells |
1 |
5 |
林東昕 |
Dongxin Lin |
腫瘤學(xué) |
Oncology |
腫瘤分子生物學(xué) |
Molecular Oncology |
2 |
6 |
鄭健 |
Jian Zheng |
腫瘤學(xué) |
Oncology |
腫瘤分子生物學(xué) |
Molecular Oncology |
1 |
7 |
文石軍 |
Shijun Wen |
腫瘤學(xué),藥物化學(xué) |
Oncology, Medicinal Chemistry |
抗腫瘤藥物及有機(jī)合成方法學(xué)研究 |
Anticancer drug discovery and the development of organic synthetic methodology |
2 |
8 |
陳帥 |
Shuai Chen |
腫瘤學(xué) |
Oncology |
免疫調(diào)節(jié)與癌變 |
Immune regulation and carcinogenesis |
2 |
9 |
唐海林 |
HailinTang |
腫瘤學(xué) |
Oncology |
腫瘤學(xué) 或 分子醫(yī)學(xué) |
Oncology or Molecular Medicine |
1 |
10 |
馬駿 |
Jun Ma |
腫瘤放射治療學(xué) |
RadiotherapyofOncology |
鼻咽癌分子預(yù)后與多學(xué)科精準(zhǔn)治療 |
Molecular prognosis and multidisciplinary precision therapy of nasopharyngeal carcinoma |
4 |
11 |
石明 |
Shi Ming |
腫瘤學(xué) |
Oncology |
肝癌 |
hepatocellular carcinoma |
1 |
12 |
邵建永 |
JianyongShao |
腫瘤學(xué) |
Oncology |
腫瘤高通量測(cè)序和數(shù)據(jù)挖掘 |
Tumor high-throughput sequencing and data mining |
1 |
13 |
李曉星 |
Xiaoxing Li |
腫瘤學(xué) |
Oncology |
腫瘤分子生物學(xué) |
Molecular Oncology |
1 |
14 |
鄭曉峰 |
腫瘤學(xué) |
Oncology |
腫瘤分子生物學(xué) |
Molecular Oncology |
3 | |
15 |
呂躍 |
Yue Lu |
腫瘤學(xué) |
Oncology |
血液腫瘤學(xué) |
Hematologic Oncology |
1 |
16 |
陳忠平 |
Zhong-ping Chen |
腫瘤學(xué) |
Oncology |
血管擬態(tài) |
Vascular mimicry |
2 |
17 |
李疆 |
Jiang Li |
腫瘤學(xué) |
Oncology |
腫瘤免疫 |
Cancer Immunology |
1 |
18 |
夏云飛 |
Yunfei Xia |
腫瘤學(xué) |
Oncology |
放射腫瘤學(xué) |
Radiation Oncology |
1 |
19 |
符立梧 |
Liwu Fu |
腫瘤學(xué) |
Oncology |
腫瘤藥理學(xué) |
Cancer Pharmacology |
3 |
20 |
關(guān)新元 |
Xin-Yuan Guan |
分子生物學(xué) |
Molecular Biology |
腫瘤微環(huán)境和腫瘤發(fā)生 |
Microenvironment and tumorigenesis |
1 |
21 |
李 焱 |
Yan Li |
腫瘤學(xué) |
Oncology |
腫瘤發(fā)生分子機(jī)制 |
Molecular tumorigenesis |
1 |
22 |
劉強(qiáng) |
Quentin Qiang Liu |
腫瘤學(xué) |
Oncology |
腫瘤分子靶向治療 |
Molecular Target Therapy |
2 |
23 |
徐瑞華 |
Rui-huaXu |
腫瘤學(xué) |
Oncology |
胃腸腫瘤精準(zhǔn)治療 |
Precise treatment in gastrointestinal cancer |
5 |
24 |
曾木圣 |
MushengZeng |
腫瘤學(xué)/病毒學(xué) |
tumor biology/virology |
EBV感染及EBV疫苗/腫瘤標(biāo)志及分子顯像/腫瘤免疫機(jī)制及免疫治療 |
EBV infection and EBV vaccine/tumor marker and molecular imaging/ Tumor immune mechanism and immunotherapy |
2 |
25 |
高嵩 |
Song Gao |
分子醫(yī)學(xué) |
Molecular Medicine |
抗腫瘤藥物靶點(diǎn)的結(jié)構(gòu)解析 |
Structural study of anti-tumor drug targets |
1 |
26 |
孫穎 |
Ying Sun |
腫瘤放射治療學(xué) |
Radiation oncology |
鼻咽癌分子預(yù)后與多學(xué)科精準(zhǔn)治療 |
Molecular prognosis and multidisciplinary precision therapy of nasopharyngeal carcinoma |
2 |
27 |
譚靜 |
Jing Tan |
腫瘤學(xué) |
Oncology |
腫瘤的精準(zhǔn)診療 |
4 | |
28 |
劉然義 |
Ran-yi Liu |
腫瘤學(xué) 或 分子醫(yī)學(xué) |
Oncology or Molecular Medicine |
惡性腫瘤靶向治療 |
Malignant tumor targeting therapy |
2 |
29 |
黃蓬 |
Peng Huang |
腫瘤學(xué),分子醫(yī)學(xué),藥學(xué) |
Oncology, molecular medicine, pharmacology |
腫瘤代謝異常的調(diào)控機(jī)制與藥物干預(yù)的研究,抗腫瘤藥物的研發(fā) |
Regulatory mechanisms of metabolic alterations in cancer and pharmacological intervention. Development of novel anticancer agents. |
3 |
30 |
李安華 |
Anhua Li |
超聲醫(yī)學(xué) |
Medical Ultrasound |
介入超聲 |
Interventional Ultrasound |
1 |
31 |
錢朝南 |
Chao-Nan Qian |
腫瘤學(xué) |
Oncology |
腫瘤轉(zhuǎn)移分子機(jī)制,或腫瘤血管劫留的分子機(jī)制 |
The molecular mechanisms underlying metastasis or vessel co-option in solid tumor |
1 |
32 |
黃文林 |
Wenlin Huang |
腫瘤學(xué) 或 分子醫(yī)學(xué) |
Oncology or Molecular Medicine |
腫瘤分子生物學(xué) |
Cancer Molecular Biology |
2 |
33 |
鄭利民 |
LiminZheng |
腫瘤學(xué) |
Oncology |
腫瘤免疫 |
Tumor immunology |
1 |
34 |
朱孝峰 |
Xiao-Feng Zhu |
腫瘤學(xué) |
Oncology |
腫瘤信號(hào)轉(zhuǎn)導(dǎo)與靶向藥物 |
Signal transduction and targeted anticancer drug |
1 |
35 |
張力 |
Zhang Li |
腫瘤學(xué) |
Medical Oncology |
1、肺癌及鼻咽癌新藥的臨床前研究;2、肺癌及鼻咽癌分子分型及靶向藥物治療研究 |
1、Studies of preclinical drug treating lung cancer and nasopharyngeal carcinoma; 2、Molecular classification and targeted drug therapy of lung cancer and nasopharyngeal cancer |
2 |
36 |
貝錦新 |
Bei Jin-Xin |
腫瘤學(xué) |
Oncology |
腫瘤遺傳學(xué)和基因組學(xué);生物信息學(xué) |
Cancer Genetics and Genomics;Bioinformatics |
2 |
37 |
謝丹 |
Dan Xie |
腫瘤學(xué) |
Oncology |
消化系統(tǒng)腫瘤轉(zhuǎn)移機(jī)制 |
The mechanisms of metastasis in GI tumors |
2 |
38 |
賈衛(wèi)華 |
Wei-HuaJia |
流行病學(xué)/腫瘤學(xué) |
Oncology/Epidemiology |
腫瘤遺傳與基因組學(xué),腫瘤流行病學(xué) |
Cancer genetics and genomes; Cancer epidemiology |
2 |
39 |
周芳堅(jiān) |
Fangjian Zhou |
腫瘤學(xué) |
Oncology |
膀胱癌發(fā)病機(jī)制的研究 |
The mechanism of bladder urothelial carcinoma |
1 |
40 |
張星 |
Xing Zhang |
腫瘤學(xué) |
Oncology |
分子靶向治療和免疫治療 |
New molecular targeted therapy and immunotherapy |
1 |
41 |
張福君 |
Fujun Zhang |
腫瘤學(xué) |
Oncology |
分子影像學(xué);腫瘤微創(chuàng)治療 |
Molecular imaging;Minimally invasive treatment of tumor |
2 |
42 |
鄧務(wù)國(guó) |
Wuguo Deng |
腫瘤學(xué) |
Oncology |
腫瘤基因表達(dá)調(diào)控 |
Tumor gene expression regulation |
2 |
43 |
夏建川 |
JianchuanXia |
免疫治療 |
immunotherapy |
腫瘤免疫治療、腫瘤病因?qū)W |
Tumor immunotherapy、Tumor etiology |
1 |
44 |
麥海強(qiáng) |
Hai-Qiang Mai |
臨床醫(yī)學(xué) |
Clinical medicine |
鼻咽癌 |
Nasopharyngeal carcinoma |
1 |
45 |
買世娟 |
Shi-Juan Mai |
腫瘤學(xué) |
Oncology |
腫瘤轉(zhuǎn)移標(biāo)志物 |
Tumor metastasis biomarker |
1 |
46 |
宋立兵 |
Li-Bing Song |
腫瘤學(xué)、分子醫(yī)學(xué) |
Oncology; Molecular medicine |
腫瘤分子機(jī)制及其標(biāo)記物 |
Molecular Mechanism & Biomarker of Tumor |
1 |
47 |
楊大俊 |
腫瘤學(xué) |
Cancer Biology and target therapy |
靶向藥物個(gè)體化治療的轉(zhuǎn)化研究 |
Anti-cancer drug research and translational research |
2 | |
48 |
曹素梅 |
Su-Mei Cao |
腫瘤流行病學(xué) |
Cancer Epidemiology |
腫瘤流行病學(xué);腫瘤篩查 |
Cancer Epidemiology |
2 |
300多萬優(yōu)質(zhì)簡(jiǎn)歷
17年行業(yè)積淀
2萬多家合作名企業(yè)
微信掃一掃 使用小程序